J&J to name change Ethicon, DePuy Synthes, Biosense Webster, Abiomed and Cerenovus.
Johnson & Johnson shared that its medical technology businesses – Ethicon, DePuy Synthes, Biosense Webster, Abiomed and Cerenovus – will now go by the name Johnson & Johnson MedTech
This is the next step of Johnson & Johnson’s updated brand and visual identity announced in September 2023. This move underscores Johnson & Johnson’s leadership in medical technology with a focus on cardiovascular, orthopaedic, surgery and vision solutions. This announcement has no impact on the medical technology products and solutions currently offered to customers.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins